抗凝固药在肝硬化中的挑战
Julia Carolin Eichholz1, Heiner Wedemeyer1,2,3,4, Benjamin Maasoumy1,5
1Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
Visceral medicine
|January 11, 2024
概括
抗凝固药物治疗可以使肝硬化患者有出血风险受益. 直接作用的口服抗凝剂显示出有前途,但对这一患者群体需要更多的研究.
科学领域:
- 血液学 血液学 血液学
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 晚期肝脏疾病显著改变静血系统.
- 肝硬化患者面临出血风险,因此应谨慎使用抗凝药.
- 本综述探讨了肝硬化患者抗凝血药物的挑战和进展.
研究的目的:
- 总结当前的挑战,建议和肝硬化患者抗凝药的发展.
- 在这个队列中评估不同抗凝剂选择的安全性和有效性.
- 突出需要进一步研究新型抗凝血剂在肝脏疾病的需要.
主要方法:
- 对肝硬化中抗凝剂的现有文献的综述.
- 在晚期肝病中分析静血系统变化.
- 抗凝剂选择的比较,包括肝素,维生素K对抗剂和直接作用的口服抗凝剂.
主要成果:
- 肝硬化中血栓事件的风险与健康个体相比或高于健康个体.
- 标准实验室标记物不足以评估血栓形成或出血风险.
- 直接作用的口服抗凝剂比传统抗凝剂具有潜在的优势.
结论:
- 抗凝药可以有益于肝病患者,如果有指示,并与出血预防.
- 直接作用的口服抗凝剂是一个有希望的进步,但需要更多的临床数据.
- 进一步的前性试验对于确定新型抗凝剂在肝硬化中的作用至关重要.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
Esophageal Varices-II: Clinical Features and Management
69
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
69
Disorders of Hemostasis
918
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
918
Diseases of the Liver and Gallbladder
549
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
549
Esophageal Varices-I: Introduction
143
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
143


